Private Label NMN 600

Private Label NMN 600

Brand: Private Label
SKU: 2525PL
20.04 USD In stock Buy at Merchant

Why Choose NMN 600 for Your Private Label? NMN (nicotinamide mononucleotide) is a compound widely recognised as a direct precursor to NAD+ (nicotinamide adenine dinucleotide), a coenzyme essential for cellular energy production and metabolic function. NAD+ plays a central role in mitochondrial activity and energy metabolism, and levels naturally decline with age. As a result, NMN supplementation is increasingly used within longevity, metabolic health, and energy-focused protocols. This formulation delivers a high-strength 600mg daily serving, providing a straightforward and practitioner-friendly approach to supporting NAD+ pathways without the need for complex combinations. Each capsule contains 300mg NMN, allowing flexibility in use depending on individual requirements or practitioner guidance. With a clean, minimal excipient profile, this product is suitable for a wide range of clients, including those following vegan or allergen-conscious protocols. Private Label Benefits Provides 600mg NMN per daily serving to support NAD+ pathways NMN acts as a precursor to NAD+, supporting cellular energy metabolism Supports nutritional strategies focused on healthy ageing and vitality Flexible dosing with 300mg per capsule for practitioner-led protocols Clean, minimal formulation suitable for sensitive or targeted use Vegan-friendly and free from gluten, dairy, and common allergens Formulation Details Key Ingredients: Nicotinamide Mononucleotide (NMN) Strength: 600mg NMN per daily serving (300mg per capsule) Format: Vegan capsules Presentation: 60 capsules (30-day supply) Free From: Gluten, dairy, GMOs and artificial additives Suitable For: Vegan and vegetarian product ranges Advisory: Food supplements should not be used as a substitute for a varied diet and healthy lifestyle.

Variants (1)
  • Default Title — 20.04 USD — In stock

AI Readiness

Good foundation, but some important product data is still missing.

83%